Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ [Acta Pharmaceutica Sinica B 13 (2023) 2585–2600]
  1. Home
  2. Publications
  3. Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ [Acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Author correction to ‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA’ [Acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Authors:
  • WZWenxin Zhang
    Wenxin Zhang
  • XPXiaohui Pan
    Xiaohui Pan
  • YXYanjun Xu
    Yanjun Xu
  • HGHongjie Guo
    Hongjie Guo
  • MZMingming Zheng
    Mingming Zheng
  • XCXi Chen
    Xi Chen
  • HWHonghai Wu
    Honghai Wu
  • QHQiaojun He
    Qiaojun He
  • LDLing Ding
    Ling Ding
  • BYBo Yang
    Bo Yang

Open Access
Publisher website
Google Scholar
  • 28 July 2023
    • journal article
    • correction
    • Published by Elsevier in Acta Pharmaceutica Sinica B
    • Vol. 13  (10) , 4337
    • DOI:10.1016/j.apsb.2023.07.023
    • PMID:37799392
    • PMCID:PMC10547944
Abstract
No abstract available
Keywords
  • ACTA PHARMACEUTICA
  • MEVALONATE IMPROVES
  • PHARMACEUTICA SINICA
  • ARTICLE DOI
  • MRNA’
  • AUTHOR CORRECTION
  • MEVALONATE
  • ACTA
  • DOI
  • PHARMACEUTICA
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.